CEO Christopher H. Hunter departs Acadia Healthcare effective Jan 20, 2026; separation agreement disclosed

Acadia Healthcare Company, Inc.

CEO Christopher H. Hunter resigned and left Board effective Jan 20, 2026; no successor named.
Hunter will receive 1.5x base salary plus target bonus payable over 18 months, plus $1.785M retention bonus.
Unvested equity awards forfeited except prorated PSUs based on time elapsed and performance.
Separation conditions include general release of claims and continued compliance with restrictive covenants.
Company retains cooperation rights; Hunter must return company property within two days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.